A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

The combined regimen achieved a higher remission rate than calorie restriction alone in people with overweight or obesity and ...

Depending on the group, participants either received 10 mg of dapagliflozin or placebo per day for 12 months. All participants were instructed to follow a calorie restriction diet with an energy ...

Interventions Calorie restriction with dapagliflozin 10 mg/day or placebo. Main outcome measures Primary outcome ... and National Nature Science Foundation of China for Distinguished Young Scholars ...

(Dapagliflozin + zibotentan) is under clinical development by AstraZeneca and currently in Phase III for Proteinuria. According to GlobalData, Phase III drugs for Proteinuria have a 33% phase ...

(Balcinrenone + dapagliflozin) is under clinical development by AstraZeneca and currently in Phase II for Proteinuria. According to GlobalData, Phase II drugs for Proteinuria have a 40% phase ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

level of <7% on canagliflozin 300 mg than on canagliflozin 100 mg (risk ratio (RR) 0.72%, 95% credible intervals (CrI) 0.59% to 0.87%) and dapagliflozin 10 mg (RR 0.63, 95% CrI 0.48 to 0.85) but there ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally ...